ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag european commission microbiology disease medicine

An illustration of green bacteria floating above neutral-colored intestinal villi
The Inside Guide: The Gut Microbiome’s Role in Host Evolution
Catherine Offord | Jul 1, 2021 | 10+ min read
Bacteria that live in the digestive tracts of animals may influence the adaptive trajectories of their hosts.
Old Politics, New Disease Clash in China
Myrna Watanabe | Jan 9, 2000 | 9 min read
©1999 Myrna WatanabeMeeting attendees at the Great Wall A 30-yuan (about $3.60) card will admit you to the Badaling entrance of China's Great Wall. But you don't just swipe it through a slot as you might at a gasoline pump or cash machine. You place the card in the slot of the magnetic strip reader and a real, live attendant will retrieve the card and hand it back to you. This is the conundrum that is China: It is using cutting-edge technologies but clinging to the old ways. This, according
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
Senior Scientists Quit Europe
Silvia Sanides | Jun 1, 2003 | 7 min read
©Paul Barton, Corbis Rigid retirement policies are prompting scientists to flee Europe at the height of their professional lives to start second careers in the United States. Many of these researchers are still conducting experiments and are in no mood to slow down. But because nearly all European universities are government run, professors are left little choice when they reach mandatory retirement age, which in most countries is 65 years or even younger. Some scientists leaving for the
How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
Week in Review: October 5–9
Tracy Vence | Oct 8, 2015 | 2 min read
This year’s Nobel Prizes; toward developing a brown fat-activating drug; certain antioxidants can increase the spread of melanoma in mice; anonymity and post-publication peer review
Fighting the 10/90 Gap
Ricki Lewis | May 12, 2002 | 5 min read
While wealthy nations pursue drugs to treat baldness and obesity, depression in dogs, and erectile dysfunction, elsewhere millions are sick or dying from preventable or treatable infectious and parasitic diseases.1 It's called the 10/90 gap. "Less than 10% of the worldwide expenditure on health research and development is devoted to the major health problems of 90% of the population," explains Els Torreele, co-chair of a working group that provided background recently for an initiative announced
Canadian CDC proposed
Ed Ungar(edungar@tht.net) | Oct 9, 2003 | 2 min read
SARS investigation prompts call for new agency to enhance and coordinate research capacity
NIH Is Advised To Expand Its International Activities
Thomas Durso | Mar 2, 1997 | 9 min read
Sidebar: Advisory Panel's Recommendations to NIH But budget concerns may force the agency's heralded Fogarty Center to stand pat A comparatively small proposed budget increase for the center that coordinates international programs of the National Institutes of Health may prevent any significant expansion of its global efforts in the near future. A report submitted last fall by an external advisory panel recommended "a strengthening of international activities" at NIH (see list of recommendatio
GM Crops Face Heat Of Debate
Ricki Lewis | Oct 10, 1999 | 10+ min read
For a successful technologyReality must take precedence over public relations, for nature cannot be fooled. --Richard Feynman Nobel physicist Richard Feynman was talking about the role NASA and its industrial partners played in the 1986 Challenger disaster, but his words could easily apply to the debate over genetically modified (GM) crops. When grain processor Archer Daniels Midland (ADM) of Decatur, Ill., asked suppliers on Sept. 2 to segregate GM corn from traditional varieties, some U.S. b

Run a Search

ADVERTISEMENT